14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $57.55 $74.44 Friday, 3rd May 2024 EXAS stock ended at $62.07. This is 2.53% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.11% from a day low at $61.47 to a day high of $63.99.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Feb 23, 2023 $65.54 $68.00 $60.58 $61.63 4 565 036
Feb 22, 2023 $61.13 $65.69 $60.97 $64.66 3 761 375
Feb 21, 2023 $62.30 $62.84 $61.01 $61.26 2 864 288
Feb 17, 2023 $62.52 $63.55 $60.94 $63.48 2 287 641
Feb 16, 2023 $63.99 $65.77 $62.82 $63.77 1 653 932
Feb 15, 2023 $65.07 $66.67 $64.62 $66.14 1 345 669
Feb 14, 2023 $65.01 $66.09 $62.94 $65.52 1 564 068
Feb 13, 2023 $64.40 $65.47 $63.80 $65.41 1 433 861
Feb 10, 2023 $64.66 $65.31 $63.39 $64.05 1 909 559
Feb 09, 2023 $69.18 $69.18 $65.88 $66.56 1 122 981
Feb 08, 2023 $68.21 $69.70 $67.71 $67.82 1 504 053
Feb 07, 2023 $67.14 $69.16 $65.83 $68.57 1 745 706
Feb 06, 2023 $66.52 $67.90 $65.14 $67.14 1 691 683
Feb 03, 2023 $68.50 $69.83 $67.09 $67.45 2 314 150
Feb 02, 2023 $70.06 $72.19 $69.43 $70.77 2 016 738
Feb 01, 2023 $67.93 $69.15 $65.07 $68.11 1 898 439
Jan 31, 2023 $66.21 $67.85 $65.92 $67.52 1 294 229
Jan 30, 2023 $66.45 $66.95 $65.15 $66.21 1 937 131
Jan 27, 2023 $64.15 $67.59 $64.00 $67.48 1 942 472
Jan 26, 2023 $65.91 $66.44 $63.79 $65.04 1 768 274
Jan 25, 2023 $63.53 $64.31 $62.27 $64.25 3 146 877
Jan 24, 2023 $67.06 $68.27 $64.90 $65.30 1 980 237
Jan 23, 2023 $68.23 $69.67 $67.01 $67.82 1 997 594
Jan 20, 2023 $67.20 $68.45 $65.01 $68.23 3 125 215
Jan 19, 2023 $66.79 $67.34 $63.00 $66.19 3 065 400
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT